drugset / Trial / NCT03896256

Ketamine for Refractory Chronic Migraine: a Pilot Study

NCT03896256

Phase 0 Completed 6 enrolled Thomas Jefferson University
NaSingle-groupOpen-labelTreatment

Summary

Ketamine is a drug used for anesthesia but at low doses it is a very effective pain reliever in several chronic conditions. Preliminary studies have shown that ketamine might be effective for patients with refractory chronic migraine, which is a severe type of headache for which patients usually have tried and failed many medications and can cause severe disability to their lives. This study will evaluate ketamine prospectively when given to patients who have "failed" an initial inpatient treatment.

Timeline

Start
2019-03-22
Primary completion
2020-01-01
Completion
2020-01-01

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Ketamine Small molecule

Indications